Leadership
Board of Directors

Leadership

The ability to serve patients with neurological diseases and their physicians begins with solid, experienced leadership. Our team of industry leaders challenges us to exceed our goals.

Martin J. Emerson

PRESIDENT AND CHIEF EXECUTIVE OFFICER

Marty Emerson joined Monteris Medical in 2016 as the President and Chief Executive Officer.  Marty has nearly 30 years of experience in the medical device industry, including Chief Executive Officer positions with both private and public companies.

Prior to joining Monteris, Marty spent eight years as the President and Chief Executive Officer of Galil Medical, a privately-held company and leader in the cryoablation systems market, leading Galil to a successful acquisition by BTG plc. He also served as President and Chief Executive Officer of American Medical Systems (AMS), a publicly-traded urology and gynecology device company with sales of over $500 million. Marty held various management positions, both domestic and international, with Boston Scientific Corporation and Baxter International. He currently serves on the Board of Directors for Incisive Surgical and Tepha Medical Devices.

Marty holds a Bachelor of Science in Accounting from Marquette University.

James Erickson

CHIEF FINANCIAL OFFICER

Jim Erickson joined Monteris Medical as the Chief Financial Officer in 2015 bringing nearly 20 years of finance leadership experience in a variety of industries.

Jim previously served in several executive financial leadership roles, including Vice President - Finance and Vice President - Controller, for Tornier, Inc., a publicly-traded, global, high-growth, extremities orthopedics company that was acquired by Wright Medical. His experience also includes a Senior Manager position within the Assurance and Advisory Services practice of the global public accounting firm Ernst & Young LLP, where he served a wide range of clients from large, publicly traded firms to small, privately-held growth stage enterprises.

Jim graduated with a Bachelor of Science in Accounting from the University of Iowa and is a Certified Public Accountant (inactive).

Ginger Glaser

CHIEF TECHNOLOGY OFFICER

Ginger Glaser joined Monteris Medical in 2016 as the Vice President of Quality and Regulatory and currently serves as the company’s Chief Technology Officer.

Prior to joining Monteris, Ginger spent 19 years at American Medical Systems (AMS), serving in a variety of executive and leadership roles in Regulatory, Quality, Project Management, Operations, and Clinical Affairs. As a Project Manager, Ginger was responsible for the oversight, development, and launch of several ground-breaking products. Ginger is regulatory affairs certified (RAC) and is highly involved in a number of industry level activities, including serving as chairperson for the joint FDA/Industry working group convened by the American Association of Medical Instrumentation (AAMI) on integrating risk-benefit assessments into post-market compliance decision-making.

Ginger received a Bachelor of Science and a Master of Science in Biomedical Engineering from Texas A&M University and completed Ph.D. coursework in Biomedical Engineering at the University of Minnesota. She was named one of "110 Women to Know in MedTech in 2017," by Becker Hospital Review.

Todd Smalley

CHIEF MARKETING OFFICER & VICE PRESIDENT, CORPORATE DEVELOPMENT

Todd Smalley joined Monteris as the company’s Chief Marketing Officer in 2018. Todd comes to Monteris from Medtronic where he spent 15 years in general management, global marketing, and corporate strategy roles. In his most recent role as Vice President and General Manager, Orthopedic Solutions, Todd led Medtronic’s entry into the $7B U.S. hip and knee replacement market.

Prior to this role, he led the European region of Medtronic’s Surgical Technologies division, including the Neurosurgery and ENT businesses. Todd also led Medtronic’s corporate strategy function, and led global marketing for its Cardiac Rhythm Management devices. Prior to his medical device career, Todd was a Management Consultant with Marakon Associates and KPMG Economic Consulting Services.

Todd is a veteran of the U.S. Navy. He holds a Bachelor of Arts in Mathematics from Cornell University and received his Master of Business Administration from The University of Chicago.

Richard Tyc

VICE PRESIDENT, TECHNOLOGY AND ADVANCED DEVELOPMENT

Richard Tyc joined Monteris Medical in 1999 and currently serves as the Vice President, Technology and Advanced Development. He is a co-inventor of the AutoLITT® technology (now the NeuroBlate® System) concept, having joined the research team at St. Boniface Hospital Research Center in 1999 working on AutoLITT technology, which later became Monteris.

Prior to working on the AutoLITT development, Richard held positions at Otto Bock Orthopedic, JCL Associates and St. Boniface General Hospital Research Center in the fields of pharmaceutical automation, industrial automation and the prosthetic device industry.

Richard is a Professional Engineer. He received a Bachelor of Science in Mechanical Engineering and a Master of Science in Mechanical and Industrial Engineering from the University of Manitoba. His development of the NeuroBlate® System led to several distinctions including the Principle Innovation Award from the Ernest C. Manning Foundation and the Governor General of Canada Innovation Award.

Andrew C. Swanson

VICE PRESIDENT, NORTH AMERICAN SALES

Andy Swanson joined Monteris in 2018 as the company’s Vice President, North American Sales. Andy has over 30 years of experience in the medical device field with a focus on capital equipment.  He most recently served as Senior Vice President, U.S. Sales for Galil Medical (acquired by BTG plc), a leader in cryoablation technology. He held additional positions with Galil since joining the company in 2003, including leadership roles within corporate accounts, sales management, clinical support, and field technical services.

Prior to his tenure at Galil, Andy held sales and territory management positions for medical device companies including Cytogen Corporation, Lifecell Corporation, and UroMed Corporation.

Andy holds a Bachelor of Arts from Auburn University.

Gord Scarth

VICE PRESIDENT, ENGINEERING – HARDWARE AND SOFTWARE

Gord Scarth joined Monteris Medical in 2015 as the Vice President of Engineering – Hardware and Software. Gord is responsible for development of the NeuroBlate® System including capital hardware and the development of the system software.

Prior to joining Monteris, Gord was Vice President of Research & Development at IMRIS, a company focused on image guided therapy solutions and surgical theatres. In this position he was responsible for development of an MR-compatible neuro-surgical robot, an integrated MR-angio system for neuro and cardiac procedures, an MR-compatible neuro-navigation system with automatic registration, and other imaging technologies. He has also worked in medical research in the areas of non-invasive neurological cancer detection/classification and functional imaging.

Gord holds a Ph.D. in Electrical Engineering from the University of Manitoba.

Lisa Hayden

VICE PRESIDENT, REIMBURSEMENT AND CHIEF COMPLIANCE OFFICER

Lisa Hayden joined Monteris Medical in 2017 and is the Vice President of Reimbursement and Chief Compliance Officer. Lisa has more than 25 years of experience in the healthcare industry and has spent the last 16 years developing reimbursement and compliance programs in the medical device space.

Prior to joining Monteris, Lisa spent 16 years at Galil Medical and BTG plc where she led the establishment of new CPT codes for cryoablation procedures, as well as advancing reimbursement initiatives outside the U.S. Lisa’s career includes physician practice management and hospital administration at Georgetown University Medical Center in Washington D.C., Suburban Hospital in Bethesda, MD, and INOVA Health in Fairfax, VA. She has also served on various working committees within AdvaMed, a leading medical technology trade association.

Lisa holds a Bachelor of Science degree in Radiologic Science from Johns Hopkins University and a Bachelor of Science degree in Clinical Leadership & Management from George Washington University.

Jordon Honeck

VICE PRESIDENT, QUALITY

Jordon Honeck joined Monteris Medical in 2016 as as the Senior Director of Quality and currently serves as the company's Vice President, Quality. Jordon’s medical device background includes over 18 years developing and delivering new technologies supporting a variety of surgical applications.

Prior to joining Monteris, Jordon led the Project Management organization at both Astora Health (formerly American Medical Systems) and Greatbatch Medical-Cardiovascular. Jordon’s experience includes leading product development programs as well as executing critical quality remediation projects. Jordon has also held a variety of leadership positions at Medtronic, including product development, marketing, program management, and research.

Jordon received a Bachelor of Science in Mechanical Engineering from the University of Minnesota and a Masters of Business Administration from St. Thomas University. Jordon is PMP Certified and holds 18 patents supporting medical device innovation.

Board of Directors

Our Board of Directors help to develop and drive the strategy to execute our vision of having our technology become a routine option in the algorithm of care for patients with neurological diseases.

Joe Biller

Joe Biller brings over a decade of experience in healthcare investment. Since joining SightLine in 2005, Joe has actively sourced and completed numerous secondary and primary transactions while assisting several portfolio companies as a Board Member or Advisor.

Prior to joining SightLine, he was a Buy-Side Investment Analyst at Bremer Asset Management.

Martin J. Emerson

Marty Emerson joined Monteris Medical in 2016 as the President and Chief Executive Officer. Marty has nearly 30 years of experience in the medical device industry, including Chief Executive Officer positions with both private and public companies.

Prior to joining Monteris, Marty spent eight years as the President and Chief Executive Officer of Galil Medical, a privately-held company and leader in the cryoablation systems market, leading Galil to a successful acquisition by BTG plc. He also served as President and Chief Executive Officer of American Medical Systems (AMS), a publicly-traded urology and gynecology device company with sales of over $500 million. Marty held various management positions, both domestic and international, with Boston Scientific Corporation and Baxter International. He currently serves on the Board of Directors for Incisive Surgical and Tepha Medical Devices.

Marty holds a Bachelor of Science in Accounting from Marquette University.

Richard Emmitt

Richard Emmitt is a General Partner of The Vertical Group, a leading venture capital firm specializing in the medical device industry, and was a founder of the firm in 1989.

Richard has over 40 years of experience in investment research, investment banking, and investment management. He has been an investor and member of the Board of Directors of several of the medical device industry’s most successful companies, including SciMed Life Systems, Xomed Surgical, American Medical Systems, ev3, Inc, and Wright Medical Group. He currently serves on the Board of Directors of Tornier, Tepha Medical, Galil Medical, and Soft Tissue Regeneration.

Richard holds a Bachelor of Arts from Bucknell University and a Master of Business Administration from the Rutgers School of Business.

William (Bill) Hoffman

Bill Hoffman has focused on early stage companies with novel devices in new markets. He is currently Chief Executive Officer of Inari Medical, which develops and sells devices designed to address venous thromboembolism disease.

Prior to Inari Medical, Bill served as Chief Executive Officer of Visualase, Inc., which developed and sold laser ablation technology for minimally invasive neurosurgery. The company was acquired by Medtronic for $105M in 2014. Bill also served as Vice President of Sales at FoxHollow Technologies, Inc., helping to build a commercial team and revenue ramp that led to a successful IPO in 2004 and an acquisition by ev3 Inc. in 2007.

Bill’s first early stage med tech experience was as head of sales for RITA Medical Systems, an interventional oncology company that launched a successful IPO in 2000. He spent the early part of his career in various sales roles at Ethicon and Medtronic.

Kirk Nielsen

Kirk Nielsen is a Managing Director at Versant Ventures. Kirk joined Versant in 2006 from Medtronic, where he worked in sales and marketing in the company’s Cardiac Rhythm Management division.

Previously, he spent time at Fluidigm (a Versant portfolio company). He also served as a consultant at Bain & Company where he advised clients in healthcare, private equity, and other industries.

Prior to his business career, Kirk was a professional hockey player. At Versant, Kirk has led or co-led investments in Biotie (public/acquired), Cameron Health (acquired), CardiAQ (acquired), Lutonix (acquired), NeuWave Medical (acquired), Sequent Medical (acquired), Ceterix Orthopaedics, Holaira, Inari Medical, Metavention, Monteris Medical, Respicardia, Veran Medical, and Zyga Technology. Based in Minneapolis, he also leads the firm’s activities in the Midwest.

Kirk earned a biology degree with honors from Harvard College, where he won the John P. Reardon, Jr. award as the school’s most outstanding scholar-athlete, and a Master of Business Administration from Harvard Business School, where he was a Baker Scholar.

Jean-François Pariseau

Jean-François Pariseau is a Partner in the Healthcare Fund of BDC Capital. He joined BDC Capital in 2001 and has over 20 years of investment and entrepreneurial experience in the healthcare sector.

Prior to joining BDC, Jean-François was an investment manager with CDP Capital Technology Ventures, a $2 billion global fund investing in healthcare, information technology and advanced technologies, where he was responsible for healthcare investments in Canada and the US.

He has invested and managed more than $200 million in biopharmaceutical and medical device companies in North America. His experience includes transactions in private and in public companies, IPOs, M&A and fund investments. Prior to this, he was Chief Executive Officer of a consulting company specializing in regulatory affairs, and was Vice President, Research & Development for a pharmaceutical-product distribution company, both of which he founded.

Jean-François currently sits on the Board of Directors of AngioChem, Clementia Pharmaceutical, Profound Medical (TSXV: PRN) and Imagia Cybernetics.

James A. Reinstein

James Reinstein has more than 25 years of medical device experience, and is currently the President, Chief Executive Officer and Board Member of Cutera, Inc., a NASDAQ listed global device company at the forefront of the medical aesthetics space.

Prior to Cutera, he was President and Chief Executive Officer of Drawbridge Health, a joint venture of GE Healthcare and GE Venture. Previous to Drawbridge, he was the President and Chief Executive Officer of Aptus Endosystems, Inc. where he led the sale of the company to Medtronic for over $100M. James also served as Executive Vice President and Chief Commercial Officer at Cyberonics, Inc. a neuromodulation company focused on helping patients with epilepsy, depression and chronic heart failure.

James spent 17 years at Boston Scientific in various roles and functions including business development, marketing and general management. Most of his career at Boston Scientific was spent working and living in Europe, Asia and Latin America.

Matt Strobeck

Matt Strobeck has served as a Director of the Company since November, 2014 and is also the Managing Partner of Birchview Capital, an investment firm focused on investing in Bioscience companies.

Matt received a Bachelor of Science from St. Lawrence University, a Ph.D. from the University of Cincinnati, an Master of Science from the Harvard University-MIT Health Sciences Technology Program and an Master of Science from the MIT Sloan School of Management.